Long-term effects of A42 immunisation in Alzheimers disease: follow-up of a randomised, placebo-controlled phase I trial
XW: Visualization, Writing original draft
In the Phase 2 trial, 100% of participants on 8mg or 12mg achieved at least 5% weight loss (the threshold for health benefits)
The multiple pharmacological treatment options will enhance clinicians ability to identify effective personalised regimens by trying a second medication or combining medications with synergistic or complimentary actions or even escalating treatment to bariatric surgery based on patient preference and underlying comorbidities [7]
I am arguing that the question of who should receive them has not been asked with nearly enough precision, and that a baseline GLP-1 measurement is an obvious, low-cost starting point
The trust that Europeans place in their healthcare systems, and which is often higher than in the U.S., is now being used against them